Topical efficacy of dimercapto-chelating agents against lewisite-induced skin lesions in SKH-1 hairless mice
| Autor: | Stéphane Mouret, Nina Nguon, Julien Wartelle, Marine Bertoni, Frédéric Dorandeu, Sandy Emorine, Cécile Cléry-Barraud, Isabelle Boudry |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Male
Pathology medicine.medical_specialty Necrosis Lewisite Administration Topical Injections Subcutaneous medicine.medical_treatment Dermatitis Pharmacology Toxicology Arsenicals Mice chemistry.chemical_compound Metal poisoning Arsenic Poisoning medicine Animals Antidote Chelating Agents Mice Hairless integumentary system business.industry Dimercaprol medicine.disease Hairless chemistry Toxicity Volatilization medicine.symptom Succimer business Infiltration (medical) medicine.drug |
| Zdroj: | Toxicology and Applied Pharmacology. 272:291-298 |
| ISSN: | 0041-008X |
| DOI: | 10.1016/j.taap.2013.06.012 |
| Popis: | Lewisite is a potent chemical warfare arsenical vesicant that can cause severe skin lesions. Today, lewisite exposure remains possible during demilitarization of old ammunitions and as a result of deliberate use. Although its cutaneous toxicity is not fully elucidated, a specific antidote exists, the British anti-lewisite (BAL, dimercaprol) but it is not without untoward effects. Analogs of BAL, less toxic, have been developed such as meso-2,3-dimercaptosuccinic acid (DMSA) and have been employed for the treatment of heavy metal poisoning. However, efficacy of DMSA against lewisite-induced skin lesions remains to be determined in comparison with BAL. We have thus evaluated in this study the therapeutic efficacy of BAL and DMSA in two administration modes against skin lesions induced by lewisite vapor on SKH-1 hairless mice. Our data demonstrate a strong protective efficacy of topical application of dimercapto-chelating agents in contrast to a subcutaneous administration 1h after lewisite exposure, with attenuation of wound size, necrosis and impairment of skin barrier function. The histological evaluation also confirms the efficacy of topical application by showing that treatments were effective in reversing lewisite-induced neutrophil infiltration. This protective effect was associated with an epidermal hyperplasia. However, for all the parameters studied, BAL was more effective than DMSA in reducing lewisite-induced skin injury. Together, these findings support the use of a topical form of dimercaprol-chelating agent against lewisite-induced skin lesion within the first hour after exposure to increase the therapeutic management and that BAL, despite its side-effects, should not be abandoned. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect